Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.
<h4>Background</h4>Chikungunya virus (CHIKV) has reemerged as a life threatening pathogen and caused large epidemics in several countries. So far, no licensed vaccine or effective antivirals are available and the treatment remains symptomatic. In this context, development of effective an...
Guardado en:
Autores principales: | Deepti Parashar, Mandar S Paingankar, Satyendra Kumar, Mangesh D Gokhale, A B Sudeep, Sapana B Shinde, V A Arankalle |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81bb83945c5745d9b113ea6fdfc03e64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking
por: Sineewanlaya Wichit, et al.
Publicado: (2017) -
Role of PDZ-binding motif from West Nile virus NS5 protein on viral replication
por: Emilie Giraud, et al.
Publicado: (2021) -
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
por: Leena Pohjala, et al.
Publicado: (2011) -
TRAF6 is a novel NS3-interacting protein that inhibits classical swine fever virus replication
por: Huifang Lv, et al.
Publicado: (2017) -
Infección grave por el virus del Chikungunya
por: Susana Ferreira-Sarmiento, et al.
Publicado: (2015)